Nuphar Veiga
The Head And Neck Cancer Research Laboratory, Tel Aviv 6423906
Tel Aviv, TA 64239, Israel
Tel Aviv, TA 64239, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Targeted nanomedicine: Lessons learned and future directions.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 30, 2022
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 20, 2021
Tumor vessel co-option probed by single-cell analysis.
Journal: Cell reports
Published: October 18, 2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.
Journal: Science advances
Published: May 22, 2020
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection.
Journal: Pharmaceutics
Published: May 05, 2020
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics.
Journal: Nature nanotechnology
Published: January 27, 2020
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes.
Journal: Advanced drug delivery reviews
Published: November 15, 2019
Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 06, 2019
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes.
Journal: Nature communications
Published: June 29, 2018
A modular platform for targeted RNAi therapeutics.
Journal: Nature nanotechnology
Published: August 08, 2016
Colitis ImmunoPET: Defining Target Cell Populations and Optimizing Pharmacokinetics.
Journal: Inflammatory bowel diseases
Published: February 04, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026